C61 – Malignant neoplasm of prostate
Coding Notes
Active
Billable, valid for HIPAA-covered transactions
Additional
code to identify:
hormone sensitivity status (Z19.1-Z19.2)
rising PSA following treatment for malignant neoplasm of prostate (R97.21)
Type 1 Excludes
malignant neoplasm of seminal vesicle (C63.7)
GEM Conversion to ICD-9 CM
Fs: 00000
–
Malignant neoplasm of prostate
MDC / MS-DRG Reference
Back Reference of Diagnostic Codes
Adenocarcinoma
See also Neoplasm, malignant, by site
duct
unspecified site
Carcinoma
(malignant)
See also Neoplasm, by site, malignant
endometrioid
unspecified site
Cystadenocarcinoma
See Neoplasm, malignant, by site
endometrioid
See Neoplasm, malignant, by site
unspecified site
Sibling Codes
View in Tabular
Code | Title |
---|---|
C00-D49 | Neoplasms (C00-D49) |
C60-C63 | Malignant neoplasms of male genital organs (C60-C63) |
C61 |
Malignant neoplasm of prostate
Use Additional
code to identify:
hormone sensitivity status (Z19.1-Z19.2)
rising PSA following treatment for malignant neoplasm of prostate (R97.21)
Type 1 Excludes
malignant neoplasm of seminal vesicle (C63.7)
|